title: Successful treatment with rituximab of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation.
authors.affiliation: *Department of Pediatrics †Department of Oncology ‡Department of Pathology and Laboratory Medicine §Department of Medical Imaging, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
authors.forename: Hilary
authors.initials: H
authors.lastname: Jericho
authors.forename: Joanna
authors.initials: J
authors.lastname: Weinstein
authors.forename: Hector
authors.initials: H
authors.lastname: Melin-Aldana
authors.forename: Katrin C
authors.initials: KC
authors.lastname: Leuer
authors.forename: Mary
authors.initials: M
authors.lastname: Wyers
authors.forename: Estella M
authors.initials: EM
authors.lastname: Alonso
authors.forename: Udeme D
authors.initials: UD
authors.lastname: Ekong
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D002675:Child, Preschool; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy* / Q000821:virology; D005260:Female; D004854:Herpesvirus 4, Human; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007890:Leiomyosarcoma / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D016031:Liver Transplantation; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D011183:Postoperative Complications / Q000188:drug therapy* / Q000821:virology; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab